Notification No. 01/2015-2020

(To be Published in the Gazette of India Extraordinary Part-H, Section - 3, Sub-Section (ii))

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi

Notification No. 01/2015-2020
New Delhi, Dated: 11^th April, 2021

Subject: Amendment in Export Policy of Injection Remdesivir and Remdesivir API.

S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendment in Schedule 2 of the ITCHS Export policy related to export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API):

S.No

ITC HS Codes

Description

Present Policy

Revised Policy

207AA

Ex 293499
Ex 300490

Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients(API)

Free

¹[Restricted]

^old[Prohibited]

2. The provision under Para 1.05 of the Foreign Trade Policy (FTP) 2015-20 regarding transitional arrangement is not applicable for this notification.

3. Effect of this Notification:

The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) falling under the ITCHS Codes specified above or falling under any other HS Code has been prohibited, with immediate effect.

(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in

(Issued from File No. 01/91/180/24/AM22/EC/E-27724)

1. Substituted Vide Notification No. 08/2015-2020 Dated 14.06.2021